
QT Sense, a deep-tech biotech startup building tools to study living cells, announced it has secured €4 million in funding to accelerate its Quantum Nuova platform, a technology that lets scientists observe cellular processes in real time and reveal biochemical activity linked to disease. The funding includes a €3 million seed investment led by Cottonwood Technology Fund, with follow-on backing from existing investor QDNL Participations and an angel investor. In addition, the company received €600,000 from the ONCO-Q programme to support cancer research and €400,000 through the Quantum Forward Challenge for collaborative deployments with research partners. Most traditional lab methods…
This story continues at The Next Web
Trending
- The Download: AI agents for science, and the “censorship-industrial complex”
- The AI Slop Backlash Is Actually Having an Impact
- These startups are chasing the next big thing in LLMs
- Meetily Lets You Transcribe and Summarize Meetings Without a Subscription—Here’s How
- These AI Barons Are Ready to Give Away Their Fortunes
- This Week’s Awesome Tech Stories From Around the Web (Through August 8)
- How to Disable Gemini in Gmail and Google Docs
- How ideas of a vast censorship network moved from the online fringe to Trump policy

